CymaBay Therapeutics Inc. (CBAY) declined -5.39% or -0.48 to $8.43. It is around 307463 shares traded, which is 54.15% compare to the average total volume 567783. The market cap of CBAY is $501.07 million. The year to date change is 2.48%. The 52 week price range is from $6.31 to $15.59. Price of CBAY have changed -6.21% during last week. It have changed 34.39% over last month, -12.99% over last 3 months, -28.49% over last 6 months and -16.96% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 9.01. It is 6.88% above current price. The 200-day Moving Averages for CBAY is 11.35. It is 34.64% above current price. The 52-week High is 15.59. It is 84.93% from the current price. The 52-week Low is 6.31. It is -25.15% from current price.
There are some statistics of CBAY. It is has market cap $501.07 million. The share outstanding is 59.44 million. The average volume is 567783. The percent of top 15 Institution holding is 123.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -42.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -37.75%.